<DOC>
	<DOCNO>NCT00703521</DOCNO>
	<brief_summary>Background . The World Health Organization recommend pre-exposure vaccination ( PreP ) protect child live canine rabies endemic country . Including PreP national childhood immunization program ( EPI ) viable option . Methods . In open-label phase II clinical trial , 200 healthy toddler randomize receive Purified Chick Embryo Cell Vaccine ( PCECV ) 3-dose Full-IM ( 1mL ) , Half-IM ( 0.5mL ) , 3-ID ( 0.1mL ) , 2-dose 2-ID ( 0.1mL ) regimen , combination two dose Japanese Encephalitis ( JEV ) , JEV alone . One booster dose PCECV ( IM ID ) JEV , JEV alone administer concomitantly one year primary vaccination . Safety evaluate injection . Blood drawn day 0 49 , one year later prior booster day 7 28 post-booster , two three year post primary vaccination . All serum analyze rabies JE virus neutralize antibody ( RVNA , JEVNA ) .</brief_summary>
	<brief_title>Rabies Immunization Concomitant With JEV Children</brief_title>
	<detailed_description />
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Male female 1218 month old toddler include study ; good health time entry study determine medical history , physical examination clinical judgment investigator ; available visit schedule study ; grant write informed consent sign parent history rabies immunization ; history Japanese encephalitis immunization disease ; significant acute chronic infectious disease time enrollment ; fever &gt; 38.0 degree C ( axillary ) or/and significant acute chronic infection require systemic antibiotic antiviral therapy within past 7 day enrollment ; treatment parenteral , oral and/or inhale corticosteroid , immunosuppressive drug specific antiinflammatory drug take chloroquine two month period enrollment ; administration vaccine within past 14 day enrollment ; know immunodeficiency autoimmune disease ; know hypersensitivity neomycin , tetracycline , amphotericinB ; plan surgery study period ; enrol investigational trial contemporaneously ; family plan leave area study site end study period ; history febrile convulsion ; history wheezing</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>rabies vaccination</keyword>
	<keyword>pre-exposure prophylaxis</keyword>
	<keyword>rabies virus neutralize antibody</keyword>
	<keyword>Antibody response</keyword>
	<keyword>immunologic memory rabies vaccination</keyword>
	<keyword>Safety rabies vaccination administer pre-exposure regimen intramuscular intradermal route</keyword>
</DOC>